Sign up to save tools and stay up to date with the latest in AI
bg
bg
1

IPA to Present at The Microcap Conference 2025

Dec 19, 2024 - financialpost.com
ImmunoPrecise Antibodies Ltd. (IPA), an AI-driven biotherapeutic research and technology company, announced its participation in The Microcap Conference 2025, scheduled for January 28-30 in Atlantic City, NJ. The conference is a major event for growth-focused companies and investors, providing a platform for companies to present their value propositions through presentations and one-on-one meetings. IPA's management team will discuss recent developments, growth strategies, and investment opportunities with institutional and individual investors.

The Microcap Conference 2025 will feature keynote speakers such as Jon Ledecky, Co-Owner of the New York Islanders, and Tom Gardner, CEO of Motley Fool, along with expert panels and presentations by financial commentators like Ron Insana and Charlie Gasparino. The event will also include entertainment by comedian Tom Papa. Hosted by DealFlow Events, the conference is known for its high-quality content, networking opportunities, and entertainment.

Key takeaways:

```html
  • ImmunoPrecise Antibodies Ltd. (IPA) will participate in The Microcap Conference 2025 in Atlantic City, NJ, from January 28-30, 2025.
  • The conference is a major event for growth-focused companies and investors, featuring keynote speakers, expert panels, and networking opportunities.
  • Keynote speakers include Jon Ledecky, Co-Owner of the New York Islanders, and Tom Gardner, CEO of Motley Fool.
  • ImmunoPrecise Antibodies Ltd. is a biotechnology company using AI and proprietary technologies to develop therapeutic antibodies.
```
View Full Article

Comments (0)

Be the first to comment!